ATEA PHARMACEUTICALS INC (AVIR) Stock Cash Flow
NASDAQ:AVIR - Nasdaq - US04683R1068 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -139.49M | -168.38M | -135.96M | -115.90M | 121.20M | |||
| Depreciation Amortization | 420.00K | 416.00K | 416.00K | 300.00K | 0.00 | |||
| Change In Working Capital | -23.08M | -7.48M | 16.16M | -46.60M | -247.80M | |||
| Other non cash items | 36.06M | 39.95M | 33.98M | 41.30M | 39.60M | |||
| OPERATING CASH FLOW | -126.06M | -135.50M | -85.39M | -121.00M | -87.00M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | 0.00 | -1.90M | 0.00 | |||
| Other Investing Activity | 84.71M | 56.10M | 40.30M | -453.50M | N/A | |||
| INVESTING CASH FLOW | 84.71M | 56.10M | 40.30M | -455.40M | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 255.00K | 267.00K | 257.00K | 400.00K | 1.50M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | -230.00K | 267.00K | 257.00K | 400.00K | 1.50M | |||
| CHANGE IN CASH | -41.58M | -79.13M | -44.84M | -576.00M | -85.50M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -126.06M | -135.50M | -85.39M | -121.00M | -87.00M | |||
| Capital Expenditure | N/A | N/A | 0.00 | -1.90M | 0.00 | |||
| FREE CASH FLOW | -126.06M | -135.50M | -85.39M | -122.90M | -87.00M | |||
All data in USD